Shanghai MicroPort Endovascular MedTech Co., Ltd. - Q3 2019 Interim Report

Original Title: Shanghai MicroPortMicroPort CardioFlowText of the Third Quarter 2019 Report of MicroPort Scientific Corporation

Shanghai MicroPort Endovascular MedTech Co., Ltd.

Company Code: 688016 Company Abbreviation: MicroPort Endovascular

Shanghai MicroPort Endovascular MedTech Co., Ltd.

I. Important Notice

1.1 The Board of Directors, the Supervisory Committee, and the directors, supervisors, and senior management of the Company hereby warrant that the contents of this quarterly report are true, accurate, and complete, with no false records, misleading statements, or material omissions, and shall bear individual and joint legal liability therefor.

1.2 All directors of the company attended the board meeting to review the quarterly report.

1.3 Peng Bo, the company’s principal executive officer; Miao Zhenghua, the principal financial officer; and Gu Jianhua, the head of the accounting department (accounting supervisor), hereby warrant that the financial statements included in this quarterly report are true, accurate, and complete.

1.4 The Company's third-quarter report is unaudited.

II. Company Overview

2.1 Key Financial Data

Unit: Yuan Currency: RMB

　　■

　　■

Non-recurring Profit and Loss Items and Amounts

√ Applicable □ Not applicable

Unit: RMB Yuan Currency: Renminbi

　　■

2.2 Table of Shareholdings by Total Number of Shareholders, Top Ten Shareholders, and Top Ten Tradable Shareholders (or Unrestricted Shareholders) as of the End of the Reporting Period

Unit: shares

　　■

2.3 Table of the Total Number of Preference Shareholders, Top Ten Preference Shareholders, and Top Ten Preference Shareholders with Unrestricted Shares as of the End of the Reporting Period

□ Applicable √ Not applicable

III. Important Matters

3.1 Significant Changes in the Company’s Major Financial Statement Items and Financial Indicators, and the Reasons Therefor

√ Applicable □ Not applicable

　　■

　　■

3.2 Analysis and Explanation of the Progress, Impact, and Solutions Regarding Significant Matters

□ Applicable √ Not applicable

3.3 Commitments Not Fulfilled Within the Specified Period During the Reporting Period

□ Applicable √ Not applicable

3.4 Warning and Explanation Regarding the Forecast That the Cumulative Net Profit from the Beginning of the Year to the End of the Next Reporting Period May Be Negative or Significantly Different from That of the Same Period Last Year

□ Applicable √ Not applicable

Company Name: Shanghai MicroPort Endovascular Medical Technology Co., Ltd.

Legal Representative: Peng Bo

Date: October 24, 2019